Description

Selank 10mg research peptide — Canada

Selank is a seven-amino-acid synthetic peptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) in which a Pro-Gly-Pro tail has been joined to tuftsin. This listing is one sealed vial of lyophilized Selank at a 10 mg labelled amount, for laboratory research only. It is our only Selank strength.

Full research overview, study table & references → Selank in Canada: research guide

Identity at a glance

Name Selank (TP-7)
Sequence TKPRPGP (7 aa)
Formula / MW C33H57N11O9 · 751.9 g/mol
CAS / UNII 129954-34-3 / TS9JR8EP1G
PubChem CID 11765600
Declared content 10 mg per vial (label value; no measured value on file)

Batch documentation: A batch-specific COA for this strength has not been posted yet — see the COA library (/coa/).

What researchers have looked at

  • Strain differences in mice (2002): Selank changed open-field behaviour and slowed plasma leu-enkephalin breakdown in BALB/c mice but had neither effect in C57Bl/6 mice[1].
  • Cortical gene expression in rats (2016): an hour after administration, 45 of 84 neurotransmission-related genes in the frontal cortex shifted, and the changes correlated with those produced by GABA[2].
  • Influenza model (2009): in cell culture and in infected mice, Selank reduced replication of an H3N2 strain most clearly when given before inoculation, alongside higher interferon-alpha gene expression[3].
  • Stability: tritium-labelling showed the peptide is cleaved in plasma into TKPRP, TKP, RP and GP, so an experiment may be measuring its fragments as well as the intact molecule[4].

These are animal and laboratory findings. A US review in 2021 called Selank poorly studied[5], and nothing here is a statement about effects in people.

Storage and handling

  • Store the sealed vial at −20 °C for the long term (site guidance: up to 24 months as dry powder); short periods cool, dry and dark are acceptable. Avoid cycling it in and out of the freezer.
  • Bacteriostatic water is sold separately. Solvent choice, concentration and method are decided by the researcher.

Also in the catalogue: Semax 10MG, a different peptide with its own records. Orders ship by Canada Post from inside Canada (shipping policy), and the whole range is on our buy peptides online in Canada page.

Review the vial record before procurement

Check the COA library for a document that matches this compound, labelled amount and lot before relying on it. The Selank Canada research guide gives background on the compound; it is not a batch record. Match the listing name, label and document identifiers, and do not carry a result over from a different peptide, strength or lot.

Frequently asked questions

Can I buy Selank 10mg in Canada?

Yes. The 10mg vial ships from inside Canada by Canada Post, so there is no customs step. It is sold for laboratory research only.

Does the Selank 10mg vial come with a certificate of analysis?

Not yet. A batch-specific COA for this strength has not been posted in the COA library, and we do not attach another product’s report in its place. This page will be updated when one is posted.

How is Selank different from Semax?

They are separate heptapeptides: Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro and Semax is Met-Glu-His-Phe-Pro-Gly-Pro. Both end in Pro-Gly-Pro, which is why they are often mentioned together (PMID 16637290), but one peptide’s records should never be used for the other.

Is Selank approved for human use?

No approval by Health Canada, the FDA or the EMA was found. A 2021 US review described it as poorly studied (PMID 34396551). This vial is for laboratory research; no dosing or administration guidance is given.

Cited

  1. Sokolov et al. (2002), Bulletin of experimental biology and medicine — PMID 12432865
  2. Volkova et al. (2016), Frontiers in pharmacology — PMID 26924987
  3. Ershov et al. (2009), Voprosy virusologii — PMID 19882898
  4. Zolotarev et al. (2006), Bioorganicheskaia khimiia — PMID 16637290
  5. Doyno et al. (2021), Journal of clinical pharmacology — PMID 34396551

For laboratory research use only. Not for human or animal consumption. No dosing, administration or protocol information is provided, and nothing here is a claim of efficacy or safety in humans.